A Study of LY3471851 in Participants With Eczema

J1P-MC-KFAD -

The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with eczema.

Trial Summary

Age Range
18 - 70 years
Conditions the trial is for
Atopic Dermatitis (Eczema)
What the trial is testing?
LY3471851, Placebo
Could I receive a Placebo?
Yes
Enrollment Goal
48
Trial Dates
Dec 4, 2019 - Jun 24, 2022
How long will I be in the trial?
The study will last up to 48 weeks and may include up to 23 visits to the study center.
Trial Phase
I

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must have been diagnosed with eczema for at least 12 months

  • Participants must have active areas of eczema

  • Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)

Participants Must Not:

  • Participants must not have received certain medications that were applied to the skin for eczema within 14 days prior to baseline (Day 1)

  • Participants must not have received certain oral or injectable medications or light therapy for eczema within 4 weeks prior to baseline

  • Participants must not have taken the study drug previously

Lilly Trial Alerts

Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.

Clinical Trial Resources

Immunology Research

To learn more about immune system conditions and ongoing clinical trials in this area, visit our Immunology Research page.

Learn More

Clinical Trial Information

A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.